Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

What if you could turn a single static image into a polished, 30-second commercial, all without hiring a production team or spending hours on editing software? Thanks to the rise of AI-powered ...

Google's Nano Banana AI image editor became something of a viral sensation when it launched last month. Now the tool is being integrated into a bunch of pre-existing Google products, like Search, ...

Design platform Figma is partnering with Google to add more AI features, the company announced on Thursday. While Figma had previously introduced AI app-building tools of its own, the new integration ...

Chiefs receiver Rashee Rice is officially back from his suspension this week, and he’s practicing on Wednesday as Kansas City gets set to play Las Vegas. Rice has not played since suffering a ...

Google's new Veo 3.1 video model has landed. It can blend individual images into a unified video clip. Like its predecessor, it also creates videos with audio. Once upon a time, animators had to ...

A collection of frames from videos generated with Veo 3.1 (Google) Google has released a new update to its Veo AI video generation model that should make it do a better job of sticking to prompts and ...

Nano Banana has been a hit in the Gemini app, and Google is now bringing the model’s (Gemini 2.5 Flash Image) viral image editing and generation to AI Mode, as well as Google Lens. On Android, there’s ...

Tourists camping out at Singapore Changi Airport overnight to escape skyrocketing hotel prices during the F1 weekend sparked public criticism among locals for tarnishing the airport’s image. A woman ...

Android Authority first spotted the image model on the AI Mode earlier this month. A beta version of the Google app showed a refreshed layout of buttons for AI Mode's prompt box, with an option to ...

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment, stands at a critical juncture as it approaches potential regulatory milestones ...